A detailed history of Klr Investment Advisors, LLC transactions in Vericel Corp stock. As of the latest transaction made, Klr Investment Advisors, LLC holds 5,519 shares of VCEL stock, worth $251,335. This represents 0.18% of its overall portfolio holdings.

Number of Shares
5,519
Holding current value
$251,335
% of portfolio
0.18%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$32.52 - $52.33 $179,477 - $288,809
5,519 New
5,519 $250 Million

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.15B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Klr Investment Advisors, LLC Portfolio

Follow Klr Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klr Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klr Investment Advisors, LLC with notifications on news.